Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : Japan Inc joins COVID-19 vaccination push as Olympics loom

06/18/2021 | 12:25am EDT
Medical workers receive doses of the vaccine against the coronavirus disease (COVID-19) at the Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital in Tokyo

TOKYO (Reuters) - Japanese corporate giants are joining the nation's COVID-19 vaccination effort ahead of the Olympic Games as the government struggles to meet its inoculation targets amid fears of a resurgence of infections.

Thousands of corporations from Toyota Motor Corp to telecom and investing outfit SoftBank Group Corp are setting up clinics in a massive private-sector vaccination drive which will begin in earnest on Monday.

The campaign, launched with the government's backing, takes added urgency with the start of the Tokyo Olympics just over a month away and fears that the influx of visitors could cause a resurgence in infections.

So far, more than 2,300 companies have applied to open vaccination centres that will give shots to about 11 million people, mainly their employees, family members and nearby residents.

"Hopefully, vaccination at the corporations will help us speed up the inoculation process," said Taro Kono, the minister in charge of the vaccine push.

"With the number of applications from the corporations, I think we can reach 1 million (doses a day) by the end of this month."

Hitting that daily rate will be critical to achieving Japan's vaccination goals, namely getting shots to all the elderly by the end of July and the rest of the adult population by November at the latest.

Just 16% of Japan's population have had at least one shot, according to a Reuters tracker, the lowest rate among comparable wealthy economies. The government's vaccination drive has been hit by manpower shortages and malfunctions in reservation systems.

To speed things up, the government charged the military to set up mass vaccination centres and liberalised rules on who can administer or get the shots.

The latest plan allowing the private sector to join the campaign leverages requirements for companies with 1,000 employees or more to have in-house doctors. Major corporations also often sport their own medical facilities and even whole hospitals that can be quickly switched to vaccination centres.

SoftBank believes it can inoculate 250,000 people, while Toyota is planning to handle 80,000.

Some small firms are joining the campaign. James Riney, the founder of venture capital firm Coral Capital, pooled the startups he has backed into a group big enough to qualify to host a vaccination centre.

"Things happen slowly in Japan until they don't," Riney said.

Vaccine hesitancy https://www.reuters.com/article/us-health-coronavirus-japan-vaccine-idINKBN2AC0BB is strong in Japan but workplace peer pressure could be even stronger, said Yoshiaki Katsuda, an occupational health expert at the Kansai University of Social Welfare.

"If a staffer has some belief in conspiracy theories or has some strong doubts about vaccinations, if their boss or colleagues get a vaccination, they would be hard-pressed to refuse it," Katsuda said.

($1 = 110.2300 yen)

(Reporting by Rocky Swift; Editing by Miyoung Kim and Stephen Coates)

By Rocky Swift

ę Reuters 2021
All news about MODERNA, INC.
10:06aMODERNA : Covid-19 3rd Wave - Federal Govt Declares Lagos, Akwa Ibom, Rivers, Ka..
09:31aMODERNA : Respiratory Syncytial Virus Vaccine mRNA-1345 Receives FDA Fast-Track ..
09:29aSanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal
09:14aMODERNA : Receives FDA Fast Track Designation for Respiratory Syncytial Virus (R..
07:35aSanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal
07:34aModerna Gets FDA Fast Track Designation for Respiratory Syncytial Virus Vacci..
06:06aASTRAZENECA : Sanwo-Olu - Lagos Recorded 4,300 Cases, 30 Fatalities in July
05:06aASTRAZENECA : Covid-19 Third Wave - Lagos Records 42 Deaths in One Week - Sanwo-..
05:06aMODERNA : Covid-19 - U.S. Delivers 4m Doses Moderna Vaccines to Nigeria to Comba..
01:53aSanofi makes $3.2 bln offer for U.S. mRNA partner Translate Bio
More news
Financials (USD)
Sales 2021 19 117 M - -
Net income 2021 10 725 M - -
Net cash 2021 11 948 M - -
P/E ratio 2021 13,7x
Yield 2021 -
Capitalization 139 B 139 B -
EV / Sales 2021 6,66x
EV / Sales 2022 7,45x
Nbr of Employees 1 300
Free-Float 90,3%
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 346,61 $
Average target price 187,80 $
Spread / Average Target -45,8%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.231.78%139 174
LONZA GROUP AG25.60%58 688
CELLTRION, INC.-26.60%31 285
SEAGEN INC.-11.93%28 062